{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Cyclamine sulfonamides as &bgr;-3 adrenergic receptor agonists", "item": "https://www.patentleaderboard.com/patent/6498170"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclamine sulfonamides as &bgr;-3 adrenergic receptor agonists

Cyclamine sulfonamides as &bgr;-3 adrenergic receptor agonists

US Patent 6498170 · Granted Dec 24, 2002

Estimated economic value: $553,843,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators2022
Naphthyridines as inhibitors of HPK12021
Oxadiazolones as transient receptor potential channel inhibitors2021
Sulfonylcycloalkyl carboxamide compounds2020
Sulfonyl pyridyl TRP inhibitors2020
Naphthyridines as inhibitors of HPK12019
Substituted sulfonamide compounds2019
Alkynyl alcohols and methods of use2017
Phosphorus containing compounds as protein kinase inhibitors2015
Methods for the use of inhibitors of cytosolic phospholipase A22011
Methods for the use of inhibitors of cytosolic phospholipase A22011
Bicyclic 6-alkylidene-penems as β-lactamase inhibitors2010